GHSI: Guardion Health Sciences, Inc. Company Value to Net Income

Corporate emblem and logo of Guardion Health Sciences Inc. (GHSI)

The share price retrospective for Guardion Health Science (GHSI) demonstrates the dynamics of a company with a multiple of -0.70. The business is subject to regulatory norms within the dietary supplement segment and a limited product line. Stability is ensured by advanced logistics and modern warehouses, while growth scales through direct online sales and brand recognition, which offsets the costs of third-party distributors.

GHSI Guardion Health Sciences Inc.: Price to Earnings Ratio in the range 07/04/2022 - 10/19/2024

Analytical breakdowns for Guardion Health Science

- price and consensus price forecast:
Stock Price guardionhealth.com|GHSI - Consensus Target
- market capitalization information:
Market Value Guardion Health Sciences, Inc.|GHSI - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share Guardion Health Sciences|GHSI - Company Net Assets|Market-to-Book Ratio guardionhealth.com|GHSI - Company Total Assets
- debt and solvency information:
Debt to Capital Guardion Health Science|GHSI - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Guardion Health|GHSI - Company Aggregate Debts|Debt to Net Assets Guardion Health Sciences, Inc.|GHSI - Company Long-Term Liabilities|Company Short-Term Debts Guardion Health Sciences|Quick Ratio guardionhealth.com
- business earnings and investment ratios data:
GHSI - Company Net Income|Expected Net Income Guardion Health Science|GHSI - P/E Multiple|Price to Future Earnings Ratio Guardion Health Sciences, Inc.|GHSI - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Guardion Health Sciences, Inc.|GHSI - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Guardion Health Sciences|GHSI - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months guardionhealth.com|GHSI - Net earnings per share growth this year|Expected earnings per share trend next year Guardion Health Science
Summary company analysis:GHSI - guardionhealth.com
Original product of Guardion Health Science

P/E determines the market value of a single unit of net profit, measuring the investment payback period. In Guardion Health Science (GHSI), this calculation accounts for ESG standard costs and eco-friendly medical nutrition packaging. By analyzing the company's historical P/E levels, an investor assesses the efficiency of raw material quality management. Low values may conceal debt risks. This indicator objectifies the issuer's fundamental value.

Competing companies

P/E Multiple alcon.com|Price to Earnings Ratio BLCO (Bausch + Lomb)|GKOS (Glaukos Corp) - Company Value to Net Income|P/E Multiple APLS (Apellis Pharmaceuticals Inc)|Belite Bio (BLTE) - Market Cap to Earnings|OCUL: Price to Earnings Ratio|Market Cap to Earnings harrowinc.com|VRDN: P/E Multiple|Market Cap to Earnings LENZ Therapeutics Inc (LENZ)|Price to Earnings Ratio Oaktree Specialty Lending|EyePoint Corp (EYPT) - Business Payback Period|P/E Multiple KOD|aldeyra.com (ALDX) - Market Cap to Net Income Ratio|KALA BIO - Price to Earnings Ratio|P/E Multiple Opus Genetics, Inc. IRD|OKYO Pharma Inc - P/E Multiple|ADVM - P/E Multiple|Outlook Therapeutics (OTLK) - Price to Earnings Ratio|clearsidebio.com - Company Value to Net Income|NBY (NovaBay Pharmaceuticals Inc.) - P/E Multiple|Price to Earnings Multiple KPRX (Kiora Pharma)|P/E Multiple ALIM|Business Payback Period eyenovia.com|Price to Earnings Ratio Ocuphire Pharma, Inc. OCUP|opthea.com (OPT) - Market Cap to Earnings